Trainer Tom Amoss has reached a settlement agreement with the Indiana Horse Racing Commission regarding a positive for a prohibited substance called sotalol in one of his runners at Horseshoe Indianapolis on Oct. 17, 2022.
A ruling detailing the settlement terms was posted April 17.
Sotalol was detected in a post-race sample from Malibu SS after he won an allowance race on Oct. 17. It was later confirmed in a split sample.
Sotalol is a beta blocker which is used to treat heart conditions in humans and has been used in some situations to treat arrhythmia in horses. According to state regulation, it is a Class 3/Penalty B substance in Indiana.
The positive is the second Penalty B finding for Amoss in 2022, after one of his runners picked up a positive for lidocaine in a June 2022 race, also at Horseshoe Indianapolis. After that ruling, Amoss said on Twitter that he was “grateful to the stewards for independently recognizing this as a possible cross-contamination.”
Amoss declined to comment on the sotalol ruling.
The terms of the settlement agreement state that Amoss is fined $5,000 and has been suspended 60 days, with 45 days being deferred. He is scheduled to serve 15 days April 15 through April 29 of this year. If Amoss incurs another Class 1, 2, or 3 positive or a Penalty A or B positive between now and Nov. 17, 2023, he will have to serve the remaining time. He has been assessed four Multiple Medication Violation points on his license. Malibu SS has also been disqualified from his win.
The post Amoss Suspended 60 Days, To Serve 15 After 2022 Positive For Beta Blocker appeared first on Horse Racing News | Paulick Report.
